Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
RRR enters the final stretch before its November 3 earnings with a split picture: the stock has bounced 6.6% on the week to $52.05, yet short interest has climbed 22% over the past month and analysts are trimming targets even as they hold constructive ratings.
The positioning story is nuanced rather than alarming. Short interest has risen to 6.8% of the free float, up from roughly 5.5% a month ago, and added another 2% in Tuesday's session alone. That is a meaningful build in percentage terms, though the absolute level remains manageable. What keeps the squeeze risk low is how loose the borrow market remains: availability runs at 503%, meaning there are more than five shares available to borrow for every one already lent out. That is well above the 52-week tightest point of 272%, which hit in mid-September. Cost to borrow is a negligible 0.45% annually. This is not a strained short book. The shorts are rebuilding on fresh conviction, not trapped by a thin lending pool. Options tell a similar story of elevated caution. The put/call ratio sits at 2.88, right in line with its 20-day average of 2.93, suggesting this week's rally has not meaningfully shifted sentiment. The PCR has been structurally elevated for months, ranging from 2.1 to 3.9 over the past 30 days, which reflects persistent demand for downside protection rather than any acute spike.
The Street is firmly in the bull camp by headcount, with 13 buys against just 3 holds, and a consensus target around $73, implying roughly 40% upside from current levels. The most recent move came Wednesday from Macquarie, where analyst Chad Beynon trimmed his target by $2 to $72 while keeping an Outperform rating. That is a minor adjustment, not a change of heart. Wolfe Research initiated in early September with an Outperform and a $73 target, adding fresh buy-side sponsorship. The bull case centres on the durability of the Las Vegas locals gaming market, near-record margins, a visible reinvestment pipeline including North Fork construction on track for a late 2026 opening, and roughly $550 million of committed spend over 2026 and 2027 that is already financed. The bear case is grounded in execution risk: Q1 EBITDA missed consensus by 3%, construction disruption at Green Valley Ranch and Durango is dragging by an estimated $11 to $12 million combined, and project timelines have slipped into summer 2027. The company's complete concentration in the Las Vegas locals market leaves no geographic buffer against macro softness or regulatory change. On valuation, the stock trades at 13.9x trailing earnings and 7.3x EV/EBITDA. Both multiples have drifted lower over the past month alongside the stock's 9% monthly decline, which has modestly improved the entry point for those who agree with the Street's growth thesis.
Ownership concentration is worth flagging. CEO Frank Fertitta III holds a 13D filing on 45.5% of the company, making this effectively a controlled stock. A second large block sits with Baron Capital at roughly 28% of shares. The two together account for nearly three-quarters of the float, which limits price discovery and amplifies moves when either side shifts. On the insider trading front, the 90-day net position shows $3 million of net selling in open-market transactions, led by a September sale from the Chief Legal Officer and August sales by the President and COO. The President's activity involved option exercises followed by immediate sales, a compensation mechanic rather than a directional call, but the net signal from open-market activity is modestly negative. Wikipedia attention for RRR has recently spiked to a z-score of 4.7 against its own 90-day history, a notable jump in retail interest that coincides with the stock's bounce this week.
RRR's most correlated peers have broadly moved in the same direction this week. PENN gained 8.9% and CBRL added 7.3%, suggesting the week's recovery in RRR reflects sector-level buying rather than any company-specific catalyst. HGV was the outlier, slipping 2.9% on the week.
The earnings date of November 3 is the natural next focal point, with investors likely to watch whether construction disruption guidance narrows and whether Las Vegas locals revenue trends held through September.
See the live data behind this article on ORTEX.
Open RRR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
